Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

UK Stocks-Factors to watch on Dec 14

Published 14/12/2015, 05:40 pm
© Reuters.  UK Stocks-Factors to watch on Dec 14
UK100
-
BP
-
CAKFF
-
AZN
-
RKT
-
RIO
-
BAES
-
RR
-
SBRY
-
LMT
-
RIO
-

Dec 14 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening down 3-4 points, or 0.05-0.07 percent lower, on Monday, according to financial bookmakers.

* Britain's top equity index closed 2.2 percent lower at 5,952.78 points on Friday as investors dumped shares in companies focused on South Africa following a reshuffle in the country's government.

* RECKITT BENCKISER: An Australian court ordered Reckitt Benckiser RB.L to pull several of its Nurofen pain relief products from the market, saying the British firm had misled consumers by marketing identical products for different types of pain.

* ROLLS ROYCE: The UK government is considering nationalising the nuclear submarine business of Rolls-Royce Holdings Plc RR.L , which powers its Trident missile deterrent system, the Financial Times reported.

* RIO TINTO: Mining group Rio Tinto RIO.L RIO.AX is set to sell French aluminium company Carbone Savoie to investment fund Alandia Industries, French daily Le Figaro said on Sunday, without citing sources.

* BP: A few months after reaching the largest corporate settlement in U.S. history, BP Plc BP.L faces a class action lawsuit in Mexico over its deadly 2010 Gulf of Mexico oil spill, which a civic group on Friday said it had filed against the company.

* ASTRAZENECA: British drugmaker AstraZeneca Plc AZN.L is in advanced talks to buy privately held cancer drug developer Acerta Pharma BV for more than $5 billion, the Wall Street Journal reported, citing people familiar with the matter.

* LOCKHEED/ BAE SYSTEMS: Lockheed Martin Corp (N:LMT) LMT.N on Friday said it had decided not to file a formal protest against contracts awarded by the U.S. Marine Corps to Science Applications International Corp SAIC.N and BAE Systems Plc BAES.L to build prototypes of a new wheeled amphibious combat vehicle.

* SAINSBURY'S: A British regulator has asked for concessions to allay competition concerns it has about German drugs distributor Celesio 's CLSGn.de planned purchase of Sainsbury 's SBRY.L pharmacy business.

* EU REFERENDUM: British Prime Minister David Cameron's office on Sunday played down reports that he was prepared to compromise on his plan to make EU migrant workers wait four years before they are allowed to claim some state benefits, a key demands for reforming Britain's relationship with the European Union, after other countries made it clear they would not accept it.

Two credit rating agencies said on Friday that Britain risked a hit to its creditworthiness and possibly a downgrade due to Prime Minister David Cameron's decision to hold a vote on whether to leave the European Union.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.